Education
About Us
Working with TipRanks
Follow Us
William Edward McKechnie Insider Profile
4 Followers
William Edward McKechnie, Director at Lexaria Bioscience, holds 31.38K shares in Lexaria Bioscience (Ticker: LEXX). Most recently, William Edward McKechnie Bought 5,000 shares of Lexaria Bioscience on Jul 30, 2025 for an estimated value of $4.50K.
William Edward McKechnie has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of William Edward McKechnie's holdings
Insider Roles
Director
Roles that William Edward McKechnie holds in companies
Most Profitable Insider Trade
The most profitable trade made by William Edward McKechnie
William Edward McKechnie's Trading History
List of latest transactions for each holding click on a transaction to see William Edward McKechnie's performance on stock
You May Also Like
William Edward McKechnie insider profile FAQ
What is the percentage of profitable transactions made by William Edward McKechnie?
The percentage of profitable transactions made by William Edward McKechnie is ―.
What is the average return per transaction made by William Edward McKechnie?
The average return per transaction made by William Edward McKechnie is ―.
What stocks does William Edward McKechnie hold?
William Edward McKechnie holds: LEXX stocks.
What was William Edward McKechnie’s latest transaction?
William Edward McKechnie latest transaction was an Informative Buy of $4.50K.
What was William Edward McKechnie's most profitable transaction?
William Edward McKechnie’s most profitable transaction was an Informative Buy of LEXX stock on July 30, 2025. The return on the trade was -7.60%.
What is William Edward McKechnie's role in Lexaria Bioscience?
William Edward McKechnie's role in Lexaria Bioscience is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.